PATENT CLAIM ANALYSIS

Application Number: 16209206
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "04400A"]

Abstract:
A method of treating a patient having an elevated inflammatory response, such as an elevated Type I interferon response, is provided. The method can be used to treat sepsis. The method comprises administering to a patient having an elevated inflammatory response, an inhibitor of anaplastic lymphoma kinase (ALK inhibitors) or expression of ALK, in an amount effective to treat the elevated inflammatory response.

Claim (Index 15):
The method of  claim 1 , wherein the inflammatory disease is inflammation associated with a viral disease.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 98.0
- Lexical Diversity: 1.67442
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15241821', '15109945', '15028813', '15564995', '15483645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8003238407909518
- 35 USC 102 Novelty (BERT): 0.5281941161841056
- Combined Prediction Score: 0.7731108683302671
- Mean Citation Score: 291.430466
- Max Citation Score: 324.42
- Similarity Product: 211.0779638171196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test